Clinical Trials
3 trialsNCT02712905 2025-11-04
An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Incyte Corporation
Phase 1/2 Terminated
NCT02959437 2025-10-21
Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)
Incyte Corporation
Phase 1/2 Terminated
NCT03514407 2025-10-21
A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma
Incyte Corporation
Phase 1 Terminated